Details for 2019818401
Up to date per 05.04.2026
Actions
Details for 2019818401
Granted/Registered
European Patent
22.09.2021 A
29.12.2021 B1
19.11.2018
US
201862769196 P
20.03.2019
US
201962821314 P
16.05.2019
US
201962848773 P
06.08.2019
US
201962883313 P
C07D 207/08 20060101AFI20200529BHEP
Owner
Global Blood Therapeutics, Inc.181 Oyster Point Blvd. South San Francisco, CA 94080US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
LI, Zhec/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard South San Francisco, CA 94080US
Information about Fees